Clinical Trial Update: Korea Post Marketing Surveillance (PMS) Study of Talzenna®

View source ↗

Summary

This is a Korea post-marketing surveillance study for Talzenna (talazoparib) focusing on breast cancer; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Talzenna (talazoparib)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Status: NOT_YET_RECRUITING